Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Drug Formulary Review Archives – July 1, 2009

July 1, 2009

View Archives Issues

  • Hospital pharmacies find budgeting a challenging process this year

    Hospitals from coast to coast are finding it more challenging to handle budgeting this year because of a variety of economic pressures.
  • Hospital budget cuts can result in changes

    Not every hospital pharmacy has experienced budget cuts this year, but with the prolonged economic downturn this is a possibility for everyone.
  • H1N1 flu is slowing down, gives room to front-line

    [Editor's note: Drug Formulary Review presents a look at how pharmacy disaster planning experts have handled the recent novel H1N1 influenza A crisis in a two-part series. In this issue, hospital pharmacy experts discuss ways to educate and prepare the public during a pandemic. Also, there's a sample H1N1 public health report and guidelines from the federal government on providing prophylaxis antiviral treatment. In the June 2009 issue, there are articles about the importance of communication during disaster preparation, and one hospital pharmacist outlines what she and her staff learned from an infectious disease disaster drill early in 2009.]
  • Antiviral influenza drug guidance

    The U. S. Department of Health and Human Services has extensive guidelines on how health care providers and public health agencies should handle an influenza pandemic.
  • Here's a sample H1N1 flu situation report

    During the early weeks of the H1N1 flu outbreak, the Florida Department of Health and Sarasota County kept health care providers and others apprised of the potential epidemic through situation reports.
  • Stocking emergency medications: Research first

    Stocking antidotes and other rarely-used emergency medications is almost an afterthought at many hospitals.
  • Drug News

    The FDA has revised information about ceftriaxone (Rocephin®) regarding its interaction with calcium-containing products.